{"count": 2, "results": [{"_id": "25052899", "pmid": 25052899, "title": "[Drug-induced liver injury caused by simvastatin associated with antinuclear antibodies].", "journal": "Med Clin (Barc)", "authors": ["Peña-Irún Á"], "date": "2015-02-20T00:00:00Z", "doi": "10.1016/j.medcli.2014.05.030", "meta_date_publication": "2015 Feb 20", "meta_volume": "144", "meta_issue": "4", "meta_pages": "189-90", "score": 50069.652, "text_hl": "[Drug-induced @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@liver injury@@@ caused by @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ associated with antinuclear @<m>DISEASE_Immunologic_Deficiency_Syndromes</m> @DISEASE_MESH:D007153 @@@antibodies@@@].", "citations": {"NLM": "Peña-Irún Á. [Drug-induced liver injury caused by simvastatin associated with antinuclear antibodies]. Med Clin (Barc). 2015 Feb 20;144(4):189-90. PMID: 25052899", "BibTeX": "@article{25052899, title={[Drug-induced liver injury caused by simvastatin associated with antinuclear antibodies].}, author={Peña-Irún Á}, journal={Med Clin (Barc)}, volume={144}, number={4}, pages={189-90}}"}}, {"_id": "19292984", "pmid": 19292984, "title": "Zocor Forte (simvastatin) has a neuroprotective effect against LPS striatal dopaminergic terminals injury, whereas against MPP+ does not.", "journal": "Eur J Pharmacol", "authors": ["Santiago M", "Hernández-Romero MC", "Machado A", "Cano J"], "date": "2009-05-01T00:00:00Z", "doi": "10.1016/j.ejphar.2009.03.026", "meta_date_publication": "2009 May 1", "meta_volume": "609", "meta_issue": "1-3", "meta_pages": "58-64", "score": 50066.156, "text_hl": "Zocor Forte (@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@) has a neuroprotective effect against @CHEMICAL_Lipopolysaccharides @CHEMICAL_MESH:D008070 @@@LPS@@@ striatal @<m>DISEASE_Immunologic_Deficiency_Syndromes</m> @DISEASE_MESH:D007153 @@@dopaminergic terminals@@@ injury, whereas against MPP+ does not.", "citations": {"NLM": "Santiago M, Hernández-Romero MC, Machado A, Cano J. Zocor Forte (simvastatin) has a neuroprotective effect against LPS striatal dopaminergic terminals injury, whereas against MPP+ does not. Eur J Pharmacol. 2009 May 1;609(1-3):58-64. PMID: 19292984", "BibTeX": "@article{19292984, title={Zocor Forte (simvastatin) has a neuroprotective effect against LPS striatal dopaminergic terminals injury, whereas against MPP+ does not.}, author={Santiago M and Hernández-Romero MC and Machado A and Cano J}, journal={Eur J Pharmacol}, volume={609}, number={1-3}, pages={58-64}}"}}]}